RCUS   $16.48  -1.49% Market Closed After Close 16.49 0.06%

Arcus Biosciences Inc
Total Cash 969.00M
totalCashPerShare 10.599
EBITDA -264.00M
Total Debt 31.00M
quickRatio 5.035
currentRatio 5.136
Total Revenue 247.00M
debtToEquity 4.882
Revenue/Share 3.021
ROA -0.14183
ROE -0.41465
grossProfits
freeCashflow -95.88M
operatingCashflow -247.00M
earningsGrowth
revenueGrowth 0.345
grossMargins -0.38462
ebitdaMargins -1.06883
operatingMargins -2.71795
profitMargins -1.0081
enterpriseValue 703.12M
forwardPE -3.705628
floatShares 51.41M
sharesOutstanding 91.43M
sharesShort 6.74M
sharesShortPriorMonth 6.62M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.41%
heldPercentInstitutions 0.59%
Short Ratio help_outline 10.53%
shortPercentOfFloat 0.15%
impliedSharesOutstanding
bookValue 6.955
Price To Book help_outline 2.46
earningsQuarterlyGrowth
netIncomeToCommon -249.00M
trailingEps -3.11%
forwardEps -4.62%
enterpriseToEbitda -2.66
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.89 3Q 2024
institutionsCount 275
lastUpdated Sept. 16, 2024, 5:42 p.m.